Participant Details for the Main Survey
| Participants: 80 Respondents: 33 Response Rate: 41% Participant Responses to Section B Questions | Regulatory Domain of Expertise | Organization Type | Pharma Experience | Years of Experience | Quality Domain of Expertise | Participant Profiles (%) |
|---|---|---|---|---|---|---|
| US FDA | 31 | 44.3 | ||||
| EU EMA | 24 | 34.3 | ||||
| Other | 15 | 21.4 | ||||
| Big Pharma | 10 | 26.3 | ||||
| Small Pharma | 5 | 13.2 | ||||
| Consulting | 16 | 42.1 | ||||
| Contract Research/Manufacturing Organization | 5 | 13.2 | ||||
| Other | 2 | 5.2 | ||||
| Pharmaceutical | 31 | 55.4 | ||||
| Biopharmaceutical | 20 | 35.7 | ||||
| Other | 5 | 8.9 | ||||
| 10–5 years | 1 | 3.0 | ||||
| 10–15 years | 2 | 6.1 | ||||
| 15+ years | 30 | 90.9 | ||||
| Good Laboratory Practice | 11 | 19.7 | ||||
| Good Manufacturing Practice | 31 | 55.4 | ||||
| Good Clinical Practice | 5 | 8.9 | ||||
| Good Research Practice | 4 | 7.1 | ||||
| Other | 5 | 8.9 |
Response rate varies by question because each respondent was allowed to choose multiple options for Section B questions with the exception of the question relating to “Years of Experience” where participants were only allowed to choose one option.